- Home
- LSF vs PDSB Comparison
LSF vs PDSB Comparison
Compare LSF & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- PDSB
- Stock Information
- Founded
- LSF 2015
- PDSB 2005
- Country
- LSF United States
- PDSB United States
- Employees
- LSF N/A
- PDSB N/A
- Industry
- LSF Packaged Foods
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- LSF Consumer Staples
- PDSB Health Care
- Exchange
- LSF Nasdaq
- PDSB Nasdaq
- Market Cap
- LSF 65.5M
- PDSB 72.2M
- IPO Year
- LSF 2020
- PDSB N/A
- Fundamental
- Price
- LSF $7.09
- PDSB $1.14
- Analyst Decision
- LSF Strong Buy
- PDSB Strong Buy
- Analyst Count
- LSF 2
- PDSB 2
- Target Price
- LSF $12.00
- PDSB $10.00
- AVG Volume (30 Days)
- LSF 32.0K
- PDSB 503.8K
- Earning Date
- LSF 08-06-2025
- PDSB 08-12-2025
- Dividend Yield
- LSF N/A
- PDSB N/A
- EPS Growth
- LSF N/A
- PDSB N/A
- EPS
- LSF N/A
- PDSB N/A
- Revenue
- LSF $45,040,358.00
- PDSB N/A
- Revenue This Year
- LSF $23.40
- PDSB N/A
- Revenue Next Year
- LSF $20.11
- PDSB N/A
- P/E Ratio
- LSF N/A
- PDSB N/A
- Revenue Growth
- LSF 25.04
- PDSB N/A
- 52 Week Low
- LSF $3.40
- PDSB $0.85
- 52 Week High
- LSF $10.90
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- LSF 55.32
- PDSB 36.27
- Support Level
- LSF $7.06
- PDSB $1.12
- Resistance Level
- LSF $7.80
- PDSB $1.27
- Average True Range (ATR)
- LSF 0.38
- PDSB 0.10
- MACD
- LSF 0.02
- PDSB 0.00
- Stochastic Oscillator
- LSF 33.64
- PDSB 23.68
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.